BCAX insider plans sale of 12,500 common shares

BCAX insider Ivan Hyep filed to sell common shares through UBS Financial Services.

Rhea-AI Filing Summary

BCAX insider Ivan Hyep filed to sell common shares through UBS Financial Services. The notice covers 12,500 common shares with an aggregate market value of $347,875.00, expected to be sold on 08/10/2026, in connection with the exercise of stock options for cash.

The filing also lists prior sales over the past three months: 9,200 common shares for $187,883.32 on 05/21/2026 and 28,000 common shares for $807,671.05 on 07/08/2026.

Key Figures

Planned shares to be sold: 12,500 shares Planned aggregate market value: $347,875.00 Prior sale on 05/21/2026: 9,200 shares for $187,883.32 +2 more

5 metrics

Planned shares to be sold 12,500 shares Common shares to be sold on 08/10/2026 in connection with stock option exercise

Planned aggregate market value $347,875.00 Aggregate market value of 12,500 common shares to be sold

Prior sale on 05/21/2026 9,200 shares for $187,883.32 Common shares sold by Ivan Hyep during the past 3 months

Prior sale on 07/08/2026 28,000 shares for $807,671.05 Additional common shares sold by Ivan Hyep during the past 3 months

Planned sale date 08/10/2026 Expected date for sale of 12,500 common shares related to option exercise

Key Terms

Form 144, Exercise of stock options, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of stock options financial

"Common | 08/10/2026 | Exercise of stock options | Issuer"

Securities To Be Sold regulatory

"NASDAQ 144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for BCAX in this Form 144 filing?

The filing discloses a planned sale of 12,500 common shares of BCAX with an aggregate market value of $347,875.00. The shares are expected to be sold on 08/10/2026 in connection with the exercise of stock options for cash.

Who is the selling security holder in the BCAX Form 144 notice?

The selling security holder is Ivan Hyep, listed with an address at 116 Huntington Avenue, Suite 703, Boston, MA 02116. The notice covers proposed sales of BCAX common stock, including shares issuable upon the exercise of stock options.

Which broker is handling the proposed BCAX share sale in this filing?

The proposed BCAX share sale will be handled by UBS Financial Services, Inc., located at 11 Madison Ave, 4th Floor, New York, NY 10010. UBS is identified in connection with the planned sale of 12,500 BCAX common shares on 08/10/2026.

What BCAX stock option exercise is associated with this Form 144?

The notice states that 12,500 common shares of BCAX are to be sold on 08/10/2026 in connection with the exercise of stock options. The transaction is described as an exercise for cash, followed by a sale of the resulting shares.

What BCAX shares were sold by Ivan Hyep in the past 3 months?

Over the past three months, Ivan Hyep sold 9,200 BCAX common shares for $187,883.32 on 05/21/2026 and 28,000 shares for $807,671.05 on 07/08/2026, according to the disclosure of prior sales.

On which market are the BCAX shares in this filing listed?

The common shares referenced in the filing are listed on NASDAQ. The Form 144 identifies NASDAQ as the trading market for the BCAX common stock involved in the planned and prior sales by the reporting holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:18 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034668
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Hyep Ivan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	12500	347875.00	65703866	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/10/2026	Exercise of stock options	Issuer			12500	08/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	05/21/2026	9200	187883.32
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	07/08/2026	28000	807671.05

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ivan Hyep
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)